Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kocher

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Vaccines|September 23, 2022
Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and DiseaseViviana Parreno, Muqun Bai, Fangning Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2014
Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patientsM Fiegl, A Pircher, C Waldthaler, et al.
Mbio|May 24, 2018
Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding ProfilesJacob F Kocher, Lisa C Lindesmith, Kari Debbink, et al.
Clinical and Translational Science|February 9, 2022
A randomized, controlled, feasibility study of RD-X19 in subjects with mild-to-moderate COVID-19 in the outpatient settingNathan Stasko, Adam S Cockrell, Jacob F Kocher, et al.
Mbio|August 24, 2017
MERS-CoV Accessory ORFs Play Key Role for Infection and PathogenesisVineet D Menachery, Hugh D Mitchell, Adam S Cockrell, et al.
Lung Cancer (Amsterdam, Netherlands)|September 22, 2024
Soluble PD-L1 shows no association to relapse and overall survival in early stage non-small cell lung cancer (NSCLC)F O Mildner, M M Sykora, H Hackl, et al.
Scientific Reports|October 19, 2021
Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissueNathan Stasko, Jacob F Kocher, Abigail Annas, et al.
Msphere|May 28, 2025
The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cellsNathan Stasko, Leslee Arwood, Nicole Jandick, et al.
Msphere|January 30, 2025
Dysregulation of lung epithelial cell homeostasis and immunity contributes to Middle East respiratory syndrome coronavirus disease severityAmy C Sims, Alexandra Schäfer, Kenichi Okuda, et al.
Leukemia|April 9, 2025
Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluidS Weinschenk, U Philipp, J C Kuehn, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Vaccines|September 23, 2022
Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and DiseaseViviana Parreno, Muqun Bai, Fangning Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2014
Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patientsM Fiegl, A Pircher, C Waldthaler, et al.
Mbio|May 24, 2018
Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding ProfilesJacob F Kocher, Lisa C Lindesmith, Kari Debbink, et al.
Clinical and Translational Science|February 9, 2022
A randomized, controlled, feasibility study of RD-X19 in subjects with mild-to-moderate COVID-19 in the outpatient settingNathan Stasko, Adam S Cockrell, Jacob F Kocher, et al.
Mbio|August 24, 2017
MERS-CoV Accessory ORFs Play Key Role for Infection and PathogenesisVineet D Menachery, Hugh D Mitchell, Adam S Cockrell, et al.
Lung Cancer (Amsterdam, Netherlands)|September 22, 2024
Soluble PD-L1 shows no association to relapse and overall survival in early stage non-small cell lung cancer (NSCLC)F O Mildner, M M Sykora, H Hackl, et al.
Scientific Reports|October 19, 2021
Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissueNathan Stasko, Jacob F Kocher, Abigail Annas, et al.
Msphere|May 28, 2025
The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cellsNathan Stasko, Leslee Arwood, Nicole Jandick, et al.
Msphere|January 30, 2025
Dysregulation of lung epithelial cell homeostasis and immunity contributes to Middle East respiratory syndrome coronavirus disease severityAmy C Sims, Alexandra Schäfer, Kenichi Okuda, et al.
Leukemia|April 9, 2025
Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluidS Weinschenk, U Philipp, J C Kuehn, et al.
Pageof 4